Sort by
Refine Your Search
-
, purified and tested for biological activity together, in a single operation taking as little as a week. You will apply this new approach to real drug targets in cancer, working at the interface of synthetic
-
approach to real drug targets in cancer, working at the interface of synthetic chemistry and biology to help speed up the discovery of new medicines. You will join an established, successful, integrated drug
-
that extend beyond current capabilities. Potential targets include queues, deques, priority structures, linked structures, and new DNA-native information architectures capable of operating in vitro or in living
-
targets across a broad spectrum of mitochondrial diseases. Supervisory Team You will join the internationally recognised Newcastle Mitochondrial Research Group, an interdisciplinary environment spanning
-
Award Summary 100% fees (UK Home only), a minimum tax-free annual living allowance of £21,805 (2026/27 UKRI rate), and a research training support grant of £20,000. Overview This PhD project targets